Advances on clinical research of blood stasis coronary heart disease angina pectoris treated with Chinese medicine

doi:10.3969/j.issn.1674-490X.2014.03.018

Abstract

Abstract: Coronary heart disease (CHD) angina pectoris is a common clinical disease with high rates of incidence, morbidity and mortality, which has a serious inlfuence on human health, especially on the mental workers aged more than 40-year-old who are in high risk. Many Chinese medical scholars were committed to the research of prevention and treatment for CHD angina pectoris all along, and they developed a number of new Chinese medicine. In this paper, the clinical research data of blood stasis CHD angina pectoris were selected, and it emphatically summarized the clinical drug efifcacy of blood stasis type of angina pectoris syndrome in recent years, as well as the research and development (R&D) status of new Chinese medicine.

Key words: coronary heart disease, angina pectoris, blood stagnation syndrome, Chinese medicine, new formulations

CLC Number:

CUI Fanyu,YANG Shaoqin. Advances on clinical research of blood stasis coronary heart disease angina pectoris treated with Chinese medicine[J]. Medical Reserch and Education, 2014, 31(3): 66-71.

References

[1] 方显明, 黄红英. 血府逐瘀汤及其制剂防治冠心病的研究进展 [J]. 中成药 2002.doi:10.3969/j.issn.1001-1528.2002.09.020
[2] 吕劲松. 血府逐瘀汤治疗冠心病150例临床观察 [J]. 中国卫生产业 2012.
[3] 朱建文, 杨延发, 杨毅文. 血府逐瘀汤合瓜蒌薤白半夏汤治疗冠心病心绞痛30例临床观察 [J]. 中医药导报 2008.doi:10.3969/j.issn.1672-951X.2008.05.018
[4] 张双伟, 冼绍祥, 杨忠奇, 张开升, ZHANG Shuangwei, XIAN Shaoxiang, YANG Zhongqi, ZHANG Kaisheng. 血府逐瘀汤干预冠心病心血瘀阻证心肌纤维化的临床研究 [J]. 广州中医药大学学报 2009.doi:10.3969/j.issn.1007-3213.2009.01.004
[5] 王未寒, Wang Weihan. 血府逐瘀汤加减治疗冠心病血瘀证U波倒置的临床观察 [J]. 浙江中医药大学学报 2009.doi:10.3969/j.issn.1005-5509.2009.02.033
[6] 李爱军. 血府逐瘀汤佐治冠心病心血瘀阻证45例临床观察 [J]. 中医药导报 2011.doi:10.3969/j.issn.1672-951X.2011.07.019
[7] 张艳华. 膈下逐瘀汤治疗冠心病心绞痛38例 [J]. 时珍国医国药 2005.doi:10.3969/j.issn.1008-0805.2005.01.040
[8] 刘立军. 桃红四物汤加减方治疗冠心病稳定型心绞痛64例 [J]. 天津中医药 2006.doi:10.3969/j.issn.1672-1519.2006.05.038
[9] 许霞, 卢桂华, 董亚华, 杨宝洪. 中西医结合治疗冠心病气虚血瘀证60例疗效观察 [J]. 中国伤残医学 2009.doi:10.3969/j.issn.1673-6567.2009.01.105
[10] 金斗镇, 杨建梅, 周端, JIN Dou-zhen, YANG Jian-mei, ZHOU Duan. 益气养阴、活血通阳法治疗冠心病心绞痛的临床研究 [J]. 新疆中医药 2007.doi:10.3969/j.issn.1009-3931.2007.03.008
[11] 郭天行. 自拟方剂丹芪活血汤治疗冠心病42例观察 [J]. 中国现代药物应用 2009.doi:10.3969/j.issn.1673-9523.2009.08.138
[12] 孟庆宏, 杨雨民, 王晓玲, 安慧萍, 赵智高. 自拟祛瘀通络汤治疗稳定型心绞痛的临床研究 [J]. 贵阳中医学院学报 2011.doi:10.3969/j.issn.1002-1108.2011.05.12
[13] 孔德梅. 步长脑心通胶囊对冠心病心绞痛患者治疗的临床观察 [J]. 中国实用医药 2009.doi:10.3969/j.issn.1673-7555.2009.33.105
[14] 马文欢, 丁之江, 李颖, 王瑞芳, MA Wen-huan, DING Zhi-jiang, LI Ying, WANG Rui-fang. 雷氏丹参片治疗冠心病心绞痛的临床疗效分析 [J]. 中成药 2005.doi:10.3969/j.issn.1001-1528.2005.08.019
[15] 王立民, 张英进. 舒血宁治疗冠心病心绞痛疗效观察 [J]. 中国医药指南 2009.doi:10.3969/j.issn.1671-8194.2009.03.042
[16] 李廉, 张志辉, 张川. 通心络胶囊治疗冠心病稳定性心绞痛的临床疗效观察 [J]. 中国医师杂志 2009.doi:10.3760/cma.j.issn.1008-1372.2009.06.063
[17] 李冰, LI Bing. 心脑通胶囊治疗冠心病60例临床观察 [J]. 上海中医药杂志 2008.doi:10.3969/j.issn.1007-1334.2008.08.010
[18] 司家亭. 血栓心脉宁治疗冠心病心绞痛35例 [J]. 中西医结合心脑血管病杂志 2009.doi:10.3969/j.issn.1672-1349.2009.01.051
[19] 罗万权, 张太珍. 银丹心脑通胶囊治疗冠心病心绞痛并高脂血症28例 [J]. 中国中医药现代远程教育 2010.doi:10.3969/j.issn.1672-2779.2010.24.044
[20] 姚丽芳. 中药心痛宁配合消心痛中西医结合治疗冠心病心绞痛 [J]. 医药前沿 2012.
[21] 王严冬, 申春悌. 香通片治疗冠心病心绞痛的疗效观察 [J]. 中国实验方剂学杂志 2009.doi:10.3969/j.issn.1005-9903.2009.06.025
[22] 史波, 杭燕, SHI Bo, HANG Yan. 麝香保心丸联合西药治疗血瘀型稳定型心绞痛65例 [J]. 实用中医内科杂志 2011.doi:10.3969/j.issn.1671-7813.2011.12.19
[23] 饶其镗, 廖利辉, 尹兴强. 加味失笑散联合生脉注射液治疗气虚血瘀型胸痹的临床分析 [J]. 中国医药指南 2012.doi:10.3969/j.issn.1671-8194.2012.08.161
[24] 崔冬梅. 参芎葡萄糖注射液治疗冠心病心绞痛临床观察 [J]. 光明中医 2008.doi:10.3969/j.issn.1003-8914.2008.04.059
[25] 王丹. 地奥心血康软胶囊治疗心血瘀阻型冠心病心绞痛的临床观察 [J]. 中医药学报 2010.doi:10.3969/j.issn.1002-2392.2010.02.053
[26] 郭伟锋, 梁彦彦, 董立君. 红花黄色素注射液治疗冠心病稳定型心绞痛(心血瘀阻证)36例 [J]. 中外医疗 2011.doi:10.3969/j.issn.1674-0742.2011.30.090
[27] 金志刚. 银丹心脑通软胶囊治疗气滞血瘀型冠心病60例 [J]. 中西医结合心脑血管病杂志 2008.doi:10.3969/j.issn.1672-1349.2008.09.002
[28] 王国栋, 孙申国, 程志国, 曾艳. 注射用蒺藜皂苷治疗心血瘀阻型冠心病心绞痛的疗效 [J]. 中国老年学杂志 2012.doi:10.3969/j.issn.1005-9202.2012.07.074
[29] 张晓华, 刘淑荣, 刘俊峰. 冠心止痛贴配合西药治疗心血瘀阻型冠心病心绞痛40例 [J]. 陕西中医 2010.doi:10.3969/j.issn.1000-7369.2010.01.024
[30] Finegold, J.A., Asaria, P., Francis, D.P.. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations [J]. International Journal of Cardiology 2013, 2(2).
[31] Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd Jones DM, Newby LK, Pina IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. [J]. Circulation: An Official Journal of the American Heart Association 2011, 11(11).
[32] Tobin KJ. Stable angina pectoris: what does the current clinical evidence tell us? [J]. JAOA: The Journal of the American Osteopathic Association 2010, 7(7).
[33] O'ROURKE S T. Antianginal actions of beta-adrenoceptor antagonists [J]. American Journal of Pharmaceutical Education 2007, 71(05).
[34] Gillian M Keating. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris. [J]. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts 2013, 1(1).
[35] Piera Capranzano, George Dangas. Late Stent Thrombosis: The Last Remaining Obstacle in Coronary Interventional Therapy [J]. Current cardiology reports 2012, 4(4).